SD0006: A Potent, Selective and Orally Available Inhibitor of p38 Kinase
Barry Burnette(Pfizer (United States)), Joseph B. Monahan(Aclaris Therapeutics (United States))
Cited by 36
Related Papers
Examination of the kinetic mechanism of mitogen-activated protein kinase activated protein kinase-2
|Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics|2002|21